{"id":"https://openalex.org/W2073391516","doi":"https://doi.org/10.1046/j.1463-1326.2000.00066.x","title":"Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro","display_name":"Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro","alternate_titles":[],"publication_year":2000,"publication_date":"2000-01-01","ids":{"openalex":"https://openalex.org/W2073391516","doi":"https://doi.org/10.1046/j.1463-1326.2000.00066.x","mag":"2073391516","pmid":"https://pubmed.ncbi.nlm.nih.gov/11220353"},"language":"en","primary_location":{"id":"doi:10.1046/j.1463-1326.2000.00066.x","doi":"https://doi.org/10.1046/j.1463-1326.2000.00066.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1463-1326.2000.00066.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2073391516"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061691275","display_name":"Edward J. Bastyr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. J. Bastyr","raw_affiliation_strings":["Eli Lilly and Company, Indianapolis, IN, USA. ejbIII@Lilly.com","Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Indianapolis, IN, USA. ejbIII@Lilly.com","institution_ids":["https://openalex.org/I168537998"]},{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052678682","display_name":"Yijian Huang","orcid":"https://orcid.org/0000-0003-4364-3199","observed_orcids":["https://orcid.org/0000-0003-4364-3199"]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y. Huang","raw_affiliation_strings":["Fred Hutchinson Cancer Research Center, Seattle, WA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fred Hutchinson Cancer Research Center, Seattle, WA, USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068141665","display_name":"Rocco L. Brunelle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. L. Brunelle","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068506691","display_name":"Louis Vignati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"L. Vignati","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060539141","display_name":"Daniel J. Cox","orcid":"https://orcid.org/0000-0002-0910-5306","observed_orcids":["https://orcid.org/0000-0002-0910-5306"]},"institutions":[{"id":"https://openalex.org/I51556381","display_name":"University of Virginia","ror":"https://ror.org/0153tk833","country_code":"US","type":"education","lineage":["https://openalex.org/I51556381"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":".D. J. Cox","raw_affiliation_strings":["University of Virginia, Health Sciences Center, Charlottesville, VA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Virginia, Health Sciences Center, Charlottesville, VA, USA","institution_ids":["https://openalex.org/I51556381"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010271204","display_name":"James G. Kotsanos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. G. Kotsanos","raw_affiliation_strings":["Eli Lilly and Company; Indianapolis, IN USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company; Indianapolis, IN USA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":0.1985,"has_fulltext":false,"cited_by_count":28,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.52392591,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"2","issue":"1","first_page":"39","last_page":"46"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.8842999935150146,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.10779999941587448,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nocturnal-hypoglycemia","display_name":"nocturnal hypoglycemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9869999885559082},{"id":"https://openalex.org/keywords/insulin-lispro","display_name":"insulin lispro","score":0.9929999709129333},{"id":"https://openalex.org/keywords/insulin-initiation","display_name":"insulin initiation","score":0.699999988079071},{"id":"https://openalex.org/keywords/health-belief-model","display_name":"Health Belief Model","score":0.7749999761581421},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.8550000190734863},{"id":"https://openalex.org/keywords/fear-of-hypoglycemia","display_name":"fear of hypoglycemia","score":0.9660000205039978},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.7860000133514404},{"id":"https://openalex.org/keywords/alcohol-consumption","display_name":"alcohol consumption","score":0.875},{"id":"https://openalex.org/keywords/diabetes-self-efficacy","display_name":"diabetes self-efficacy","score":0.6639999747276306}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8941694498062134},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6862423419952393},{"id":"https://openalex.org/C2776486108","wikidata":"https://www.wikidata.org/wiki/Q3492616","display_name":"Insulin lispro","level":4,"score":0.6353532075881958},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5990160703659058},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5931686162948608},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5657207369804382},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5434551239013672},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.4745655357837677},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.43313270807266235},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.41080036759376526},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3387409448623657},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000428","descriptor_name":"Alcohol Drinking","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001294","descriptor_name":"Attitude to Health","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002940","descriptor_name":"Circadian Rhythm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061268","descriptor_name":"Insulin Lispro","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1463-1326.2000.00066.x","doi":"https://doi.org/10.1046/j.1463-1326.2000.00066.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1463-1326.2000.00066.x","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:11220353","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11220353","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306089","display_name":"American Diabetes Association","ror":"https://ror.org/04f6cgz95"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1986705681","https://openalex.org/W2008006848","https://openalex.org/W2017847166","https://openalex.org/W2018083384","https://openalex.org/W2023534497","https://openalex.org/W2035123305","https://openalex.org/W2046635118","https://openalex.org/W2054896794","https://openalex.org/W2078089300","https://openalex.org/W2081528927","https://openalex.org/W2085381118","https://openalex.org/W2101481281","https://openalex.org/W2114102308","https://openalex.org/W2134740567","https://openalex.org/W2141835999","https://openalex.org/W2145920204","https://openalex.org/W2163213453","https://openalex.org/W2188846692","https://openalex.org/W2337454357","https://openalex.org/W2425536499","https://openalex.org/W2444665414","https://openalex.org/W2769264260","https://openalex.org/W2783993460","https://openalex.org/W2995133996","https://openalex.org/W3147894994","https://openalex.org/W4234050533","https://openalex.org/W4239317507","https://openalex.org/W4245899290","https://openalex.org/W4252759459"],"related_works":["https://openalex.org/W2744362804","https://openalex.org/W2085381118","https://openalex.org/W2392463295","https://openalex.org/W2003778247","https://openalex.org/W2044103984","https://openalex.org/W2781430083","https://openalex.org/W4283652465","https://openalex.org/W1978155012","https://openalex.org/W2407700391","https://openalex.org/W2491328855"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"identify":[2],"factors":[3,238],"associated":[4,129,144,208],"with":[5,10,41,121,130,149,209,228],"nocturnal":[6,118,125,163,226,247],"hypoglycaemia":[7,71,119,126,145,164,204,227,248],"in":[8,93,173,183],"patients":[9,50,90,100,217,245],"type":[11,87,242],"2":[12,18,88,215,243],"diabetes":[13,194,244],"who":[14,154],"were":[15,91,180],"new":[16,218],"(<":[17],"months":[19],"therapy)":[20],"to":[21,63,186,219,246],"insulin":[22,39,122,141,220,229,251],"therapy.":[23,142,252],"METHODS:":[24],"A":[25,45],"randomised,":[26],"multicentre,":[27],"12-month":[28],"parallel":[29],"open-label":[30],"study":[31,114],"compared":[32],"the":[33,64,94,102,113,156,174],"clinical":[34,79],"safety":[35,80],"and":[36,73,81,85,96,110,138,236],"efficacy":[37],"of":[38,47,55,70,211,225],"lispro":[40],"regular":[42],"human":[43],"insulin.":[44],"cohort":[46],"North":[48,98],"American":[49,99],"completed":[51,101,155],"a":[52,199],"health-related":[53],"quality":[54],"life":[56],"(HRQOL)":[57],"questionnaire":[58],"which":[59],"included":[60],"questions":[61],"related":[62],"Health":[65],"Beliefs":[66],"Model":[67],"(HBM).":[68],"Measurements":[69],"rate":[72],"short-and":[74],"long-term":[75],"glucose":[76],"control":[77,187,195],"assessed":[78],"efficacy.":[82],"Three":[83],"hundred":[84],"sixty-five":[86],"diabetic":[89,216],"enrolled":[92],"study,":[95],"195":[97],"HRQOL":[103,157],"questionnaire.":[104],"RESULTS:":[105],"After":[106],"adjustment":[107],"for":[108,162],"demographic":[109],"psychological":[111,237],"factors,":[112],"population":[115],"demonstrated":[116,159,222],"lower":[117,136,148,223],"risk":[120,127,146,161,205,224],"lispro.":[123,230],"Higher":[124],"was":[128,147,206],"reduced":[131],"body":[132],"mass":[133],"index":[134],"(b.m.i.),":[135],"age,":[137],"basal":[139],"ultralente":[140],"The":[143],"increased":[150],"alcohol":[151],"consumption.":[152],"Patients":[153],"survey":[158],"higher":[160],"if":[165],"they:":[166],"(1)":[167],"had":[168],"more":[169,181],"troublesome":[170],"hyperglycaemia":[171],"symptoms":[172],"week":[175],"before":[176],"starting":[177],"insulin;":[178],"(2)":[179],"confident":[182],"their":[184,188],"ability":[185],"diabetes;":[189],"or":[190],"(3)":[191],"thought":[192],"that":[193,239],"did":[196],"not":[197],"offer":[198],"clear":[200],"health":[201],"benefit.":[202],"Nocturnal":[203],"inversely":[207],"fear":[210],"hypoglycaemia.":[212],"CONCLUSIONS:":[213],"Type":[214],"therapy":[221],"Practitioners":[231],"should":[232],"consider":[233],"patient":[234],"characteristics":[235],"may":[240],"predispose":[241],"when":[249],"initiating":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2073391516","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
